Multi-system Supplement

Sulforaphane (preformed)

one sponsorform-specific Grade and summary pending review Evidence Grade Strength of published clinical evidence — not a safety rating or a recommendation. How to read this

Dimension Scores

Human Outcome

•

Biomarker Relevance

•

Signal Source Quality

•

Organ Specificity

•

Interaction Certainty

•

Translational Maturity

•

Per-dimension evidence strength is part of the full analysis Unlock full analysis

No indication-level signals recorded yet. The grade above has not been decomposed, so it should be read as a whole-compound assessment rather than a claim about any one indication.

Evidence Summary

Preformed sulforaphane requires no conversion step, so the dose reaching the bloodstream is more predictable than with precursor forms. Human trials report changes in detoxification and inflammatory markers rather than clinical outcomes. Much of the published work clusters around a single research group and an associated commercial preparation, so effect sizes are best read as upper bounds.

Evidence Signals (0)

🔒

Create a free account to see signal-level evidence grades.

Create a free account

Products Containing Sulforaphane (preformed)

No commercial products are currently listed for this molecule.

This evidence profile reflects publicly available research as of October 22, 2026. Evidence grades may change as new research is published. ClinEvident grades the quality of published evidence — it does not evaluate the efficacy of any specific commercial product.